Information  X 
Enter a valid email address

Iofina PLC (IOF)

  Print      Mail a friend       Annual reports

Tuesday 10 March, 2020

Iofina PLC

Requisition of General Meeting

RNS Number : 5683F
Iofina PLC
10 March 2020
 

 

 

10 March 2020

 

Iofina plc

("Iofina" or the "Company")

 

 

Requisition of General Meeting

 

Iofina plc (AIM: IOF), specialists in the exploration and production of iodine and manufacturers of specialty chemical products, announces that the Company has received a letter dated 9 March 2020 from Rene Nominees (IOM) Limited A/C POOLED (the "Requisitioner") on behalf of beneficial owners, Southern Rock Insurance Company Limited and ICS Risk Solutions Limited , regarding a purported requisition for Iofina to convene a general meeting ("GM") pursuant to section 303 of the Companies Act 2006 (as amended), to propose the following ordinary resolutions:

1.  That Lance Baller be removed as a Director of the Company.

2.  That Arron Banks be appointed as a Director of the Company.

Among other things, the Requisitioner's letter further informed the Company that the Requisitioner is the registered holder of a total of 20,251,255 ordinary shares in the capital of the Company, which represents approximately 10.56% of the voting rights in the Company.

Iofina is currently seeking advice in relation to the validity of the purported requisition.  Shareholders are advised to take no action at this time. Further announcements will be made in due course.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Enquiries

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Matthew Radley (corporate finance)

Camille Gochez (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Joe Burgess

Yellow Jersey PR Limited

Tel: +44 (0)20 3004 9512

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCJMMFTMTBBMIM

a d v e r t i s e m e n t